Analyzing Jim Cramer’s “7 Best Stocks For 2023”

Jim Cramer is one of the most hated people in financial media.

He’s mocked constantly, and there’s even an “Inverse Cramer ETF” that does the opposite of whatever Jim Cramer recommends.

Personally, I don’t like bullying. And I’d rather use my time to learn from successful investors. But, a recent article titled “Jim Cramer says these 7 stocks will be winners in 2023” caught my eye. So today, we’re looking at all seven of Cramer’s picks and whether or not they’re good investments.

Here we go!

1. Eli Lilly and Company ($LLY)

Eli Lilly is a well-established pharmaceutical giant.

The company was founded in 1876, and is currently one of the three largest insulin producers in the world, alongside Sanofi and Novo Nordisk.

Eli Lilly has delivered staggering shareholder returns over the past 10 years, compounding at an average annual rate of 25.07%. That’s enough to turn an initial $10,000 into $93,540.38.

So far so good, and it’s easy to see why Cramer recommends this business.